Project
GSE58827: Dynamics of the Mouse Liver
Navigation
Downloads
Results for Mecp2
Z-value: 3.09
Motif logo
Transcription factors associated with Mecp2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
Mecp2
|
ENSMUSG00000031393.17 | methyl CpG binding protein 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Mecp2 | mm39_v1_chrX_-_73129195_73129296 | 0.82 | 7.5e-10 | Click! |
Activity profile of Mecp2 motif
Sorted Z-values of Mecp2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of Mecp2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.3 | 17.4 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 3.4 | 10.1 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
| 3.0 | 8.9 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
| 2.8 | 8.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 2.7 | 10.6 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.3 | 9.3 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 2.3 | 7.0 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
| 2.2 | 8.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 2.2 | 4.3 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
| 2.2 | 21.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 2.0 | 20.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 2.0 | 10.0 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 2.0 | 8.0 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 1.9 | 7.7 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 1.9 | 5.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 1.9 | 15.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.9 | 5.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.8 | 14.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 1.8 | 5.4 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
| 1.7 | 1.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 1.7 | 8.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 1.7 | 5.0 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 1.6 | 4.9 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.6 | 8.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.6 | 4.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.6 | 4.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 1.6 | 6.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 1.6 | 4.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 1.6 | 7.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.5 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 1.5 | 4.5 | GO:0044206 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
| 1.5 | 13.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.5 | 4.4 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 1.5 | 7.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 1.4 | 9.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 1.4 | 4.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.3 | 5.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 1.3 | 5.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 1.3 | 5.3 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
| 1.3 | 7.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.3 | 15.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.3 | 5.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 1.3 | 6.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.3 | 6.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 1.3 | 5.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 1.3 | 6.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.3 | 3.8 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
| 1.3 | 2.5 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.2 | 5.0 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 1.2 | 6.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.2 | 6.2 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 1.2 | 1.2 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
| 1.2 | 7.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.2 | 6.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 1.2 | 8.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 1.2 | 3.6 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.2 | 1.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 1.2 | 3.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 1.2 | 1.2 | GO:0035844 | cloaca development(GO:0035844) |
| 1.2 | 4.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 1.2 | 3.5 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 1.2 | 1.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 1.1 | 3.4 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 1.1 | 6.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.1 | 3.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.1 | 6.6 | GO:0015871 | choline transport(GO:0015871) |
| 1.1 | 13.1 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
| 1.1 | 6.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 1.1 | 3.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 1.1 | 3.2 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 1.1 | 2.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 1.1 | 3.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
| 1.1 | 4.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.0 | 3.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.0 | 2.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 1.0 | 7.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.0 | 11.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 1.0 | 5.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.0 | 5.2 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 1.0 | 3.1 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
| 1.0 | 6.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 1.0 | 3.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 1.0 | 5.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 1.0 | 1.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 1.0 | 2.9 | GO:0015825 | L-serine transport(GO:0015825) |
| 1.0 | 4.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 1.0 | 1.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.0 | 4.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 1.0 | 4.8 | GO:0044849 | estrous cycle(GO:0044849) |
| 1.0 | 1.9 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.9 | 2.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.9 | 2.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.9 | 3.7 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
| 0.9 | 9.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.9 | 0.9 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.9 | 3.7 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.9 | 2.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.9 | 2.7 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.9 | 0.9 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.9 | 1.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.9 | 1.8 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
| 0.9 | 1.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.9 | 2.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.9 | 6.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.9 | 2.6 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
| 0.9 | 5.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.9 | 5.1 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.8 | 0.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 0.8 | 3.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.8 | 7.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.8 | 2.5 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.8 | 3.3 | GO:0021592 | fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.8 | 0.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.8 | 3.3 | GO:0003017 | lymph circulation(GO:0003017) |
| 0.8 | 11.5 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 0.8 | 2.4 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.8 | 3.2 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.8 | 3.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.8 | 0.8 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.8 | 3.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.8 | 2.4 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.8 | 2.4 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
| 0.8 | 2.4 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.8 | 0.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.8 | 2.4 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.8 | 4.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 | 3.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.8 | 0.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.8 | 0.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.8 | 3.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.8 | 3.8 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.8 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.7 | 0.7 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.7 | 3.0 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.7 | 0.7 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.7 | 1.5 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.7 | 2.2 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
| 0.7 | 3.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.7 | 6.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.7 | 4.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.7 | 2.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.7 | 2.9 | GO:0015904 | tetracycline transport(GO:0015904) |
| 0.7 | 2.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.7 | 2.9 | GO:0045425 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) cellular response to molecule of fungal origin(GO:0071226) |
| 0.7 | 3.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.7 | 3.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.7 | 1.4 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
| 0.7 | 2.8 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.7 | 8.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.7 | 3.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.7 | 4.2 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.7 | 2.1 | GO:1903413 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
| 0.7 | 0.7 | GO:0034092 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.7 | 2.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.7 | 0.7 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.7 | 27.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.7 | 0.7 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
| 0.7 | 3.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 | 2.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.7 | 2.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.7 | 6.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.7 | 2.8 | GO:0046722 | lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.7 | 4.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.7 | 2.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.7 | 2.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.7 | 0.7 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.7 | 4.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.7 | 22.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.7 | 6.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.7 | 0.7 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 0.7 | 2.7 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.7 | 2.0 | GO:0045004 | DNA replication proofreading(GO:0045004) |
| 0.7 | 0.7 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
| 0.7 | 2.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.7 | 2.0 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.7 | 2.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.7 | 9.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.7 | 2.0 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
| 0.7 | 6.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.6 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.6 | 5.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.6 | 3.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.6 | 1.9 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.6 | 3.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.6 | 7.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.6 | 3.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.6 | 9.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.6 | 3.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.6 | 1.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.6 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
| 0.6 | 1.2 | GO:0097017 | renal protein absorption(GO:0097017) |
| 0.6 | 9.9 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.6 | 2.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.6 | 7.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.6 | 9.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.6 | 14.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.6 | 0.6 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.6 | 1.8 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.6 | 1.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.6 | 4.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.6 | 3.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
| 0.6 | 0.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.6 | 1.2 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.6 | 1.8 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.6 | 3.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.6 | 2.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
| 0.6 | 4.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.6 | 4.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.6 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.6 | 2.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.6 | 11.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.6 | 1.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.6 | 3.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.6 | 6.9 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.6 | 2.9 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.6 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.6 | 0.6 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.6 | 3.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.6 | 1.7 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.6 | 5.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.6 | 2.8 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
| 0.6 | 2.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.6 | 6.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.6 | 5.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 | 2.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.6 | 3.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.6 | 1.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.6 | 2.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.6 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.6 | 10.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.6 | 2.8 | GO:0036257 | multivesicular body organization(GO:0036257) |
| 0.6 | 1.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.6 | 1.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.5 | 3.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 | 1.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.5 | 1.6 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
| 0.5 | 3.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.5 | 1.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 3.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.5 | 3.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.5 | 1.1 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.5 | 4.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.5 | 2.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.5 | 3.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.5 | 0.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.5 | 4.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 | 7.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.5 | 3.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.5 | 16.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.5 | 8.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.5 | 2.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.5 | 2.1 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.5 | 2.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.5 | 1.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.5 | 8.2 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.5 | 1.5 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.5 | 2.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.5 | 3.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.5 | 0.5 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.5 | 6.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.5 | 0.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.5 | 2.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.5 | 2.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.5 | 3.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.5 | 0.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.5 | 3.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.5 | 2.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.5 | 3.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 | 6.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.5 | 0.5 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.5 | 3.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.5 | 1.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
| 0.5 | 1.0 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
| 0.5 | 1.0 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.5 | 1.5 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.5 | 1.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 | 7.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.5 | 3.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 | 5.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.5 | 3.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.5 | 3.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.5 | 0.5 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.5 | 3.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 | 1.4 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.5 | 1.9 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.5 | 6.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.5 | 2.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 | 4.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.5 | 2.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.5 | 1.9 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
| 0.5 | 15.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.5 | 1.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.5 | 2.3 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.5 | 1.9 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.5 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 0.5 | 3.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.5 | 8.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.5 | 2.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.5 | 1.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.5 | 1.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 10.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.5 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.5 | 2.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.5 | 0.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.5 | 8.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
| 0.4 | 1.8 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.4 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 31.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.4 | 8.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.4 | 0.4 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.4 | 5.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.4 | 2.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.4 | 2.2 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.4 | 1.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 0.4 | 1.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 | 2.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.4 | 41.7 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.4 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 2.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.4 | 3.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 | 6.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.4 | 3.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.4 | 1.3 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
| 0.4 | 0.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.4 | 1.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 | 8.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.4 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 | 1.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.4 | 1.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.4 | 27.8 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.4 | 0.8 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.4 | 6.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.4 | 5.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.4 | 5.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.4 | 2.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.4 | 2.1 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.4 | 1.7 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) |
| 0.4 | 2.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.4 | 5.8 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.4 | 4.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.4 | 2.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.4 | 3.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.4 | 3.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.4 | 2.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 | 4.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 | 0.8 | GO:0030421 | defecation(GO:0030421) |
| 0.4 | 2.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.4 | 1.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.4 | 4.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.4 | 4.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.4 | 0.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.4 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.4 | 0.4 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.4 | 1.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.4 | 1.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.4 | 4.3 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.4 | 1.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.4 | 0.4 | GO:0001966 | thigmotaxis(GO:0001966) |
| 0.4 | 0.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.4 | 10.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.4 | 3.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.4 | 5.4 | GO:0007099 | centriole replication(GO:0007099) |
| 0.4 | 1.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 | 1.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.4 | 4.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.4 | 2.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.4 | 1.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.4 | 1.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 0.4 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.4 | 7.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.4 | 1.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.4 | 0.8 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 | 1.1 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.4 | 1.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.4 | 3.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.4 | 1.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 | 1.1 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.4 | 1.5 | GO:0010286 | heat acclimation(GO:0010286) |
| 0.4 | 4.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.4 | 15.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.4 | 1.8 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.4 | 4.0 | GO:0008228 | opsonization(GO:0008228) |
| 0.4 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 | 1.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.4 | 2.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.4 | 1.4 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.4 | 2.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.4 | 0.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.4 | 1.8 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.4 | 2.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.4 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.4 | 2.8 | GO:0031179 | peptide modification(GO:0031179) |
| 0.4 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.4 | 2.5 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.3 | 6.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.3 | 8.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.3 | 4.9 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.3 | 2.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 | 0.3 | GO:0072710 | response to hydroxyurea(GO:0072710) |
| 0.3 | 2.1 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.3 | 1.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.3 | 2.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 | 1.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 1.0 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.3 | 2.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.3 | 4.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.3 | 1.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.3 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.3 | 1.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
| 0.3 | 1.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.3 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
| 0.3 | 3.1 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.3 | 6.1 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.3 | 2.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 | 1.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 1.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 4.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.3 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 9.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.3 | 1.3 | GO:0072537 | fibroblast activation(GO:0072537) |
| 0.3 | 1.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.3 | 2.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.3 | 0.3 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.3 | 2.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 | 1.0 | GO:1990859 | cellular response to endothelin(GO:1990859) |
| 0.3 | 3.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.3 | 23.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.3 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 | 1.3 | GO:1904349 | positive regulation of small intestine smooth muscle contraction(GO:1904349) |
| 0.3 | 1.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.3 | 2.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 | 3.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 0.6 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 | 3.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 | 1.8 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 0.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 | 0.9 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.3 | 3.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.3 | 2.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.3 | 0.6 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
| 0.3 | 0.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.3 | 3.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.3 | 2.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.3 | 2.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.3 | 2.1 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
| 0.3 | 2.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.3 | 1.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.3 | 6.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.3 | 4.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 | 1.4 | GO:0052405 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.3 | 5.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.3 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 1.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 | 2.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.3 | 2.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.3 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 | 1.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.3 | 1.4 | GO:0009597 | detection of virus(GO:0009597) |
| 0.3 | 2.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.3 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 2.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.3 | 3.7 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.3 | 0.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.3 | 3.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.3 | 4.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 | 4.2 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.3 | 1.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.3 | 0.3 | GO:2000834 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) regulation of testosterone secretion(GO:2000843) |
| 0.3 | 4.8 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.3 | 0.8 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.3 | 1.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.3 | 1.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 0.8 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 | 2.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.3 | 0.8 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 0.3 | 0.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.3 | 0.8 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.3 | 0.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.3 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.3 | 4.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.3 | 1.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.3 | 2.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.3 | 2.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.3 | 2.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.3 | 6.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.3 | 2.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 1.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 | 4.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.3 | 0.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.3 | 1.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 0.8 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 0.3 | 7.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 | 2.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.3 | 1.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 | 1.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 | 2.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.3 | 1.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
| 0.3 | 0.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 | 1.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.3 | 1.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.3 | 2.6 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.3 | 3.1 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.3 | 2.0 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.3 | 1.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.3 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 | 0.5 | GO:0060003 | copper ion export(GO:0060003) |
| 0.2 | 3.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.2 | 1.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.2 | 2.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.2 | 2.7 | GO:0010458 | exit from mitosis(GO:0010458) |
| 0.2 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.2 | 9.9 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 0.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 | 0.5 | GO:1902946 | protein localization to early endosome(GO:1902946) |
| 0.2 | 2.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 4.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 0.5 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.2 | 1.4 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 2.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.2 | 1.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.2 | 0.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.2 | 0.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 1.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.2 | 0.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.2 | 2.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 0.5 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 | 2.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 1.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 | 3.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.2 | 1.6 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.2 | 13.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 2.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.2 | 4.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 | 0.7 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 | 0.2 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.2 | 4.2 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.2 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 0.7 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 0.2 | 0.9 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.2 | 1.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.2 | 4.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.2 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 | 3.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 | 0.4 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 | 1.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.2 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.2 | 1.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.2 | 2.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.2 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.2 | 3.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 4.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.2 | 0.6 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 0.6 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.2 | 4.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.4 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 | 5.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 0.8 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.2 | 1.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.2 | 0.4 | GO:0006154 | adenosine catabolic process(GO:0006154) |
| 0.2 | 1.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
| 0.2 | 0.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 2.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.2 | 3.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 | 0.4 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.2 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 0.4 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.2 | 3.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.2 | 1.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.2 | 5.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 4.8 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.2 | 5.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 1.0 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.2 | 3.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
| 0.2 | 0.4 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.2 | 1.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 0.6 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.2 | 0.6 | GO:0042245 | RNA repair(GO:0042245) |
| 0.2 | 0.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.2 | 3.0 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 6.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.2 | 8.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.2 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 1.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 | 1.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 0.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.2 | 1.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 0.2 | 3.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.2 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 | 3.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
| 0.2 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.2 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.2 | 2.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 1.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.2 | 1.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 | 0.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.2 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 1.8 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 0.2 | 1.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 1.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.2 | 10.8 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.2 | 0.4 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 0.2 | 1.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 0.5 | GO:0090399 | replicative senescence(GO:0090399) |
| 0.2 | 0.4 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.2 | 1.1 | GO:0015867 | ATP transport(GO:0015867) |
| 0.2 | 1.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.2 | 2.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 | 1.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 1.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 12.6 | GO:0000910 | cytokinesis(GO:0000910) |
| 0.2 | 0.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 | 0.4 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.2 | 1.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.2 | 1.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.2 | 0.9 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
| 0.2 | 1.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 2.4 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.2 | 0.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.2 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 1.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.2 | 4.7 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.2 | 1.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.2 | 0.7 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.2 | 0.8 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 0.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
| 0.2 | 1.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.2 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 | 1.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 1.5 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 2.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.2 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
| 0.2 | 1.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 | 0.2 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
| 0.2 | 1.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.2 | 4.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 0.5 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.2 | 2.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 | 0.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.2 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.2 | 0.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.2 | 0.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 | 1.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 0.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 | 2.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 | 0.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 | 1.2 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
| 0.2 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 | 0.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.2 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.2 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.2 | 5.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.1 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 5.0 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.1 | 1.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.1 | 0.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.1 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
| 0.1 | 1.1 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 0.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 | 0.7 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.1 | 1.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 | 1.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 1.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 | 0.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 2.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.7 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 | 0.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.1 | 5.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 2.0 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 | 0.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 0.9 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.1 | 0.7 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 0.1 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 | 0.7 | GO:0001821 | histamine secretion(GO:0001821) |
| 0.1 | 0.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 | 1.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.1 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.4 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
| 0.1 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.1 | 3.0 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 0.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.1 | 0.5 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.1 | 0.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 | 1.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 1.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 2.7 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.8 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 0.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.4 | GO:0015881 | creatine transport(GO:0015881) |
| 0.1 | 1.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.1 | 0.4 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
| 0.1 | 1.6 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 2.2 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 1.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.5 | GO:0042168 | heme metabolic process(GO:0042168) |
| 0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 | 0.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 1.2 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 0.1 | 5.4 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.1 | 2.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.6 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.1 | 0.9 | GO:0007100 | mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
| 0.1 | 1.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 6.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.1 | 0.8 | GO:0003283 | atrial septum development(GO:0003283) |
| 0.1 | 1.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.1 | 0.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.1 | 0.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.5 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 | 3.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 0.9 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 2.0 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.1 | 1.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.1 | 2.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 3.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 2.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.2 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.1 | 1.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
| 0.1 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.1 | 0.3 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 | 1.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.1 | 0.6 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.1 | 4.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 1.7 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.1 | 0.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 | 0.3 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 4.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 11.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 1.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 1.7 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 | 13.0 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.1 | 2.7 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.1 | 2.7 | GO:0061515 | myeloid cell development(GO:0061515) |
| 0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.1 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 0.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 | 0.3 | GO:0097156 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) regulation of modification of synaptic structure(GO:1905244) |
| 0.1 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 3.0 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 1.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 2.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.4 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.1 | 1.9 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 3.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 2.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 2.6 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.2 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.1 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.4 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
| 0.1 | 0.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 1.7 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 2.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.1 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 1.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 | 0.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
| 0.1 | 0.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 2.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.1 | 0.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.1 | 2.5 | GO:0038202 | TORC1 signaling(GO:0038202) |
| 0.1 | 1.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 0.6 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 0.2 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.6 | GO:0042026 | protein refolding(GO:0042026) |
| 0.1 | 0.3 | GO:0042713 | positive regulation of serotonin secretion(GO:0014064) negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) sperm ejaculation(GO:0042713) |
| 0.1 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.1 | 3.5 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.1 | 0.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.5 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 0.2 | GO:0048313 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 1.0 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
| 0.1 | 0.4 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 | 8.2 | GO:0000398 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.1 | 2.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 0.2 | GO:1904266 | regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
| 0.1 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.3 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
| 0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.1 | 0.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 1.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.1 | 0.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 1.5 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
| 0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.1 | 0.7 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 0.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 | 6.5 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.1 | 1.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.8 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.1 | 1.8 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
| 0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 1.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 1.5 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.1 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 | 0.4 | GO:0006405 | RNA export from nucleus(GO:0006405) |
| 0.1 | 0.3 | GO:1990743 | protein sialylation(GO:1990743) |
| 0.1 | 1.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.1 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.1 | 0.8 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.1 | 0.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.1 | 0.5 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
| 0.0 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.2 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
| 0.0 | 2.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
| 0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 1.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 | 0.4 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.0 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.0 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.0 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.0 | 0.1 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.0 | 0.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 | 0.5 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.0 | 0.5 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.0 | 0.8 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.0 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 | 0.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 | 0.7 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 | 0.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
| 0.0 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.0 | 1.6 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.3 | GO:0015809 | arginine transport(GO:0015809) |
| 0.0 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 | 0.4 | GO:0009220 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
| 0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.0 | 0.2 | GO:0043217 | myelin maintenance(GO:0043217) |
| 0.0 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.0 | 0.3 | GO:2000209 | regulation of anoikis(GO:2000209) |
| 0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.0 | GO:0061038 | uterus morphogenesis(GO:0061038) |
| 0.0 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 2.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 | 0.1 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
| 0.0 | 0.0 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) positive regulation of mucus secretion(GO:0070257) |
| 0.0 | 0.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 0.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.0 | 0.0 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.0 | 1.5 | GO:0009615 | response to virus(GO:0009615) |
| 0.0 | 0.1 | GO:0016073 | snRNA metabolic process(GO:0016073) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 11.2 | GO:0001740 | Barr body(GO:0001740) |
| 2.6 | 7.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 2.5 | 12.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 2.5 | 10.0 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 2.3 | 14.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 2.0 | 16.0 | GO:0008091 | spectrin(GO:0008091) |
| 2.0 | 7.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.9 | 5.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 1.9 | 11.3 | GO:0031523 | Myb complex(GO:0031523) |
| 1.9 | 5.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.7 | 5.2 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 1.6 | 6.5 | GO:0035101 | FACT complex(GO:0035101) |
| 1.6 | 4.8 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 1.6 | 11.0 | GO:0000796 | condensin complex(GO:0000796) |
| 1.5 | 4.6 | GO:0034455 | t-UTP complex(GO:0034455) |
| 1.5 | 4.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.5 | 11.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 1.5 | 5.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 1.4 | 9.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.4 | 5.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 1.4 | 4.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 1.3 | 7.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 1.3 | 7.7 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 1.3 | 8.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.2 | 6.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 1.2 | 3.7 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 1.2 | 8.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 1.2 | 3.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 1.2 | 2.3 | GO:0044393 | microspike(GO:0044393) |
| 1.1 | 1.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 1.1 | 8.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.1 | 4.3 | GO:0071920 | cleavage body(GO:0071920) |
| 1.0 | 3.1 | GO:0000811 | GINS complex(GO:0000811) |
| 1.0 | 21.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 1.0 | 14.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.0 | 6.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.9 | 10.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.9 | 2.8 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.9 | 5.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.9 | 7.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.9 | 7.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.9 | 11.5 | GO:0005818 | aster(GO:0005818) |
| 0.9 | 3.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.9 | 8.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.9 | 5.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.9 | 5.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.8 | 5.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.8 | 1.6 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.8 | 2.5 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.8 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.8 | 7.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.8 | 4.0 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.8 | 14.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.7 | 3.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.7 | 5.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.7 | 2.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.7 | 3.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.7 | 12.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.7 | 2.1 | GO:1990879 | CST complex(GO:1990879) |
| 0.7 | 4.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.7 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.7 | 3.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.7 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.7 | 2.0 | GO:0090537 | CERF complex(GO:0090537) |
| 0.7 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.7 | 8.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.7 | 6.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.6 | 10.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.6 | 5.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.6 | 9.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.6 | 3.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.6 | 1.9 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.6 | 1.9 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
| 0.6 | 10.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.6 | 1.9 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.6 | 1.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.6 | 2.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 6.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.6 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.6 | 2.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.6 | 2.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.6 | 2.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.6 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.6 | 5.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.6 | 2.3 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
| 0.6 | 5.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.6 | 11.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.6 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.6 | 6.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.6 | 7.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.6 | 7.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
| 0.6 | 44.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.5 | 2.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.5 | 6.4 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.5 | 3.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.5 | 3.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.5 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.5 | 7.8 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.5 | 3.1 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.5 | 5.2 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.5 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.5 | 8.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.5 | 17.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.5 | 1.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.5 | 1.5 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.5 | 3.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.5 | 2.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.5 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.5 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
| 0.5 | 4.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.5 | 1.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.5 | 1.4 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.5 | 6.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.5 | 3.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.5 | 1.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.4 | 4.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.4 | 4.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.4 | 4.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.4 | 3.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.4 | 2.1 | GO:0043293 | apoptosome(GO:0043293) |
| 0.4 | 1.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.4 | 2.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 2.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.4 | 9.7 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.4 | 2.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.4 | 3.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.4 | 1.6 | GO:0008623 | CHRAC(GO:0008623) |
| 0.4 | 13.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.4 | 2.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.4 | 1.6 | GO:0030891 | VCB complex(GO:0030891) |
| 0.4 | 4.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.4 | 2.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 19.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.4 | 6.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.4 | 2.4 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.4 | 9.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
| 0.4 | 2.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.4 | 2.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.4 | 17.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.4 | 2.7 | GO:0071914 | prominosome(GO:0071914) |
| 0.4 | 2.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.4 | 1.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.4 | 1.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.4 | 12.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 7.2 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.4 | 1.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.4 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.4 | 8.2 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.4 | 36.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.4 | 1.8 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.4 | 1.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.4 | 3.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.3 | 5.2 | GO:0042581 | specific granule(GO:0042581) |
| 0.3 | 2.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.3 | 1.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 8.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.3 | 3.8 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 1.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.3 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
| 0.3 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 5.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 8.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.3 | 15.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.3 | 0.3 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.3 | 1.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.3 | 0.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.3 | 3.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.3 | 6.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.3 | 6.7 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.3 | 1.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.3 | 0.6 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.3 | 0.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.3 | 1.6 | GO:0034448 | EGO complex(GO:0034448) |
| 0.3 | 10.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 1.3 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 0.3 | 0.9 | GO:0034657 | GID complex(GO:0034657) |
| 0.3 | 2.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.3 | 2.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.3 | 10.3 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.3 | 14.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.3 | 1.2 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 2.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.3 | 3.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.3 | 5.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.3 | 4.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 15.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.3 | 3.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 5.5 | GO:0034708 | methyltransferase complex(GO:0034708) |
| 0.3 | 3.5 | GO:0042555 | MCM complex(GO:0042555) |
| 0.3 | 2.0 | GO:0016234 | inclusion body(GO:0016234) |
| 0.3 | 0.9 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 1.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.3 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 4.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.3 | 6.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 18.5 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.3 | 1.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.3 | 23.7 | GO:0000922 | spindle pole(GO:0000922) |
| 0.3 | 7.4 | GO:0005605 | basal lamina(GO:0005605) |
| 0.3 | 2.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.3 | 22.3 | GO:0000776 | kinetochore(GO:0000776) |
| 0.3 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 11.2 | GO:0002102 | podosome(GO:0002102) |
| 0.3 | 3.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.3 | 0.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 0.5 | GO:0070992 | translation initiation complex(GO:0070992) |
| 0.3 | 2.6 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.3 | 8.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 0.8 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.3 | 2.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 2.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 19.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.2 | 2.4 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.2 | 1.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.2 | 4.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 2.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.2 | 9.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.2 | 1.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.2 | 24.6 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 2.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.2 | 0.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 4.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.2 | 1.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.2 | 16.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.2 | 1.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 2.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.2 | 2.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 1.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 0.6 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 0.2 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 3.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 12.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.2 | 1.6 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.2 | 4.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 2.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 1.8 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.2 | 7.9 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 1.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.2 | 2.3 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 0.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 21.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.2 | 19.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 3.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 12.8 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 18.4 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.2 | 1.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 0.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 1.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.2 | 3.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 1.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 1.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 1.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 8.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.9 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 1.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 5.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 7.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 0.7 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.1 | 2.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.1 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 7.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.5 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.1 | 2.4 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 8.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 6.7 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 1.7 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 0.4 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.1 | 2.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.1 | 19.0 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 10.5 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 29.0 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 1.4 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.7 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.1 | 1.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.1 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.9 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.1 | 1.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.1 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 26.3 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 4.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 3.7 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 0.8 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.1 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 30.6 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.1 | 0.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 0.1 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 0.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 3.6 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 1.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 0.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.1 | 3.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 0.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.1 | 2.1 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.1 | 8.3 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.0 | 4.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 1.8 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.0 | 1.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 1.6 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.0 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 0.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 6.2 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 28.0 | GO:0005829 | cytosol(GO:0005829) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.5 | 13.6 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 2.1 | 6.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 1.9 | 5.7 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.8 | 5.4 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 1.8 | 12.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.8 | 17.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.7 | 8.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.7 | 5.0 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 1.7 | 16.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.6 | 4.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.6 | 4.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.6 | 11.0 | GO:0002135 | CTP binding(GO:0002135) |
| 1.6 | 4.7 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 1.6 | 6.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 1.5 | 7.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.5 | 7.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.5 | 7.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 1.4 | 4.1 | GO:0003896 | DNA primase activity(GO:0003896) |
| 1.3 | 6.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 1.3 | 7.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 1.3 | 5.2 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
| 1.3 | 7.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 1.3 | 3.9 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.3 | 6.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 1.2 | 10.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 1.2 | 11.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 1.2 | 3.5 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.1 | 1.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 1.1 | 6.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.1 | 6.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.1 | 7.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.1 | 4.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
| 1.0 | 6.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.0 | 9.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.0 | 4.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 1.0 | 12.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.0 | 3.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 1.0 | 3.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.0 | 1.0 | GO:0034046 | poly(G) binding(GO:0034046) |
| 1.0 | 4.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 1.0 | 7.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.9 | 4.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.9 | 5.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.9 | 3.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.9 | 2.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.9 | 1.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.9 | 3.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.9 | 3.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.9 | 5.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.8 | 2.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.8 | 9.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.8 | 4.9 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.8 | 2.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.8 | 5.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.8 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.8 | 4.7 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.8 | 5.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.8 | 2.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.8 | 23.2 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.8 | 3.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.8 | 3.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.8 | 3.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.8 | 2.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.7 | 2.2 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.7 | 7.5 | GO:0043559 | insulin binding(GO:0043559) |
| 0.7 | 5.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.7 | 5.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.7 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.7 | 2.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.7 | 2.9 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
| 0.7 | 6.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.7 | 8.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.7 | 3.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.7 | 3.6 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 0.7 | 1.4 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.7 | 1.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.7 | 20.2 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.7 | 2.1 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.7 | 2.7 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.7 | 2.0 | GO:0019002 | GMP binding(GO:0019002) |
| 0.7 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.7 | 4.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.7 | 2.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.7 | 3.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.7 | 2.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.7 | 11.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.6 | 2.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.6 | 4.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.6 | 3.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.6 | 2.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.6 | 24.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.6 | 2.5 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.6 | 4.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.6 | 3.7 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.6 | 1.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.6 | 1.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.6 | 5.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.6 | 5.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.6 | 1.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.6 | 9.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.6 | 6.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.6 | 1.8 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.6 | 2.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.6 | 4.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.6 | 3.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.6 | 1.7 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
| 0.6 | 1.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.6 | 6.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.6 | 2.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.6 | 5.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.6 | 11.1 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.5 | 2.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.5 | 2.2 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.5 | 3.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.5 | 2.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.5 | 8.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.5 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.5 | 1.6 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.5 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.5 | 2.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.5 | 2.1 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 0.5 | 1.5 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.5 | 3.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.5 | 2.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 4.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.5 | 5.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.5 | 4.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.5 | 8.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.5 | 1.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.5 | 3.0 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
| 0.5 | 3.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.5 | 2.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.5 | 5.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.5 | 2.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.5 | 7.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.5 | 19.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.5 | 1.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.5 | 2.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.5 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.5 | 1.9 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.5 | 1.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.5 | 2.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.5 | 1.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.5 | 1.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.5 | 16.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.5 | 10.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.5 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.5 | 1.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.5 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.5 | 2.8 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.5 | 2.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.5 | 1.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.5 | 1.4 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
| 0.5 | 1.4 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.4 | 1.8 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.4 | 2.2 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.4 | 1.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.4 | 3.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.4 | 2.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.4 | 2.7 | GO:0070728 | leucine binding(GO:0070728) |
| 0.4 | 3.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.4 | 11.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 3.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.4 | 2.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.4 | 1.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.4 | 11.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.4 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.4 | 1.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.4 | 5.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.4 | 0.4 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.4 | 14.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.4 | 3.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.4 | 3.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.4 | 0.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.4 | 62.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.4 | 2.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 1.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.4 | 1.2 | GO:0004135 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
| 0.4 | 1.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.4 | 1.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.4 | 4.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.4 | 9.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.4 | 0.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.4 | 13.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.4 | 2.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.4 | 6.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.4 | 1.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.4 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.4 | 1.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.4 | 2.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.4 | 9.5 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 8.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.4 | 2.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 2.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 4.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.4 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.4 | 3.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 3.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.4 | 8.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 1.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.4 | 0.8 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
| 0.4 | 1.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.4 | 8.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.4 | 1.1 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.4 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.4 | 1.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.4 | 1.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.4 | 6.0 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.4 | 4.8 | GO:0046790 | virion binding(GO:0046790) |
| 0.4 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.4 | 7.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.4 | 1.5 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.4 | 2.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.4 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.4 | 3.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.4 | 1.8 | GO:0019767 | IgE receptor activity(GO:0019767) |
| 0.4 | 1.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.4 | 1.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.4 | 7.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.3 | 2.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 4.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.3 | 2.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.3 | 1.4 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
| 0.3 | 1.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.3 | 2.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.3 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 3.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.3 | 6.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.3 | 4.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 0.3 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.3 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 2.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.3 | 7.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 2.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.3 | 2.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.3 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.3 | 1.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.3 | 3.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.3 | 0.9 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
| 0.3 | 0.9 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.3 | 3.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 0.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 0.6 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.3 | 1.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.3 | 0.6 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.3 | 3.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 0.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.3 | 4.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.3 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 1.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 1.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.3 | 2.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.3 | 1.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.3 | 1.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.3 | 0.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.3 | 2.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.3 | 0.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 1.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.3 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 12.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.3 | 5.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.3 | 0.8 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
| 0.3 | 5.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.3 | 2.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.3 | 5.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 1.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.3 | 1.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.3 | 1.1 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
| 0.3 | 6.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.3 | 1.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.3 | 5.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.3 | 0.8 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.3 | 4.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.3 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 0.8 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
| 0.3 | 1.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.3 | 1.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.3 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 3.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.3 | 5.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 23.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.3 | 6.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.3 | 10.8 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.3 | 1.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.3 | 0.8 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
| 0.3 | 8.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.3 | 3.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.3 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.3 | 6.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 15.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.3 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.3 | 2.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 4.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.3 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 1.0 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
| 0.2 | 1.0 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 1.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.2 | 1.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.2 | 1.2 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.2 | 2.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.2 | 1.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.2 | 0.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.2 | 7.9 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 1.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.2 | 11.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.2 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 2.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 19.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.2 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 2.8 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 3.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 0.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.2 | 1.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.2 | 0.7 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 0.2 | 0.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.2 | 1.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.2 | 1.4 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 5.2 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 0.7 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
| 0.2 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.2 | 5.9 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.2 | 1.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.2 | 1.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.2 | 0.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.2 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 0.7 | GO:0001729 | ceramide kinase activity(GO:0001729) |
| 0.2 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 0.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 2.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 1.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.2 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.2 | 2.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 2.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 1.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 7.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 4.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 3.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 0.6 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.2 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 3.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.2 | 0.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 0.2 | 2.3 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 10.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 4.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.6 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
| 0.2 | 2.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 0.6 | GO:0035516 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
| 0.2 | 10.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 25.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.2 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.2 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.2 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 1.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.2 | 2.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 1.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 2.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.2 | 1.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 0.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.2 | 3.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 1.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.2 | 3.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 2.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.6 | GO:0004557 | alpha-galactosidase activity(GO:0004557) alpha-N-acetylgalactosaminidase activity(GO:0008456) |
| 0.2 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 4.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.2 | 4.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 2.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.2 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.2 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 0.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 28.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 5.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 3.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.2 | 2.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 0.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.2 | 5.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 6.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 3.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 4.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.2 | 1.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.2 | 3.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.2 | 0.3 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.2 | 1.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.2 | 8.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.2 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 2.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 0.8 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 0.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 2.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 6.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 1.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.2 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 0.8 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 1.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 2.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 3.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 3.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 54.4 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.1 | 21.0 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 1.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 4.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 1.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 2.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.8 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.1 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.1 | 4.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 10.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 3.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 4.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 0.9 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.1 | 2.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 7.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 2.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 1.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.1 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
| 0.1 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 12.0 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 2.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 1.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.1 | 0.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.1 | 1.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 6.5 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 2.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 4.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 2.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 4.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 3.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.7 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.1 | 2.7 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 0.4 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
| 0.1 | 0.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.1 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 0.4 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
| 0.1 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.3 | GO:0070540 | stearic acid binding(GO:0070540) |
| 0.1 | 1.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 18.7 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 22.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 5.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 9.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 1.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.1 | 0.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 3.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.4 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
| 0.1 | 1.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.7 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.1 | 2.0 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.1 | 4.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 2.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.1 | 0.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 2.4 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.2 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.1 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 0.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
| 0.1 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 4.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.1 | 79.0 | GO:0003723 | RNA binding(GO:0003723) |
| 0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 1.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 1.3 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.1 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.1 | 3.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.3 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.1 | 0.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.1 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 1.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 18.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 3.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.2 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.1 | 1.6 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.0 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.0 | 0.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.0 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.0 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.0 | 1.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 2.1 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
| 0.0 | 0.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 2.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 3.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.0 | 1.1 | GO:0042805 | actinin binding(GO:0042805) |
| 0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.0 | 0.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.0 | 2.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 2.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.0 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.0 | 4.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.1 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.0 | GO:0004904 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 69.9 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.0 | 18.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.9 | 57.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.7 | 15.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.6 | 30.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.6 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.6 | 13.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.5 | 3.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.5 | 47.4 | PID E2F PATHWAY | E2F transcription factor network |
| 0.5 | 3.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.5 | 1.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.4 | 1.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 4.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.4 | 14.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 6.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.4 | 4.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 29.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.4 | 23.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.4 | 11.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.4 | 20.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 9.2 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.3 | 1.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 9.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.3 | 7.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.3 | 7.1 | PID ATR PATHWAY | ATR signaling pathway |
| 0.3 | 20.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.3 | 34.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.3 | 19.1 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.3 | 12.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.3 | 9.3 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.3 | 10.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.3 | 11.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 4.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 11.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 14.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.2 | 8.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 3.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 1.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 3.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.2 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 5.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.2 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 7.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.2 | 5.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.2 | 3.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 2.2 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.2 | 5.2 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 8.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 3.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 5.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 10.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 5.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 11.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 0.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 6.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 7.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 3.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 3.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.2 | 8.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 2.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 3.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 12.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 4.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 3.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 9.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 8.2 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 2.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 10.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 1.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 3.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.1 | PID BCR 5PATHWAY | BCR signaling pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 28.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 2.0 | 2.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.4 | 22.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 1.3 | 24.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 1.3 | 6.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 1.3 | 12.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 1.1 | 1.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 1.1 | 29.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 1.0 | 14.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.9 | 7.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.9 | 14.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.9 | 16.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.9 | 16.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.8 | 9.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.8 | 1.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.8 | 18.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.7 | 20.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.7 | 1.4 | REACTOME S PHASE | Genes involved in S Phase |
| 0.6 | 27.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.6 | 0.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.6 | 1.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 4.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.6 | 4.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.6 | 17.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.6 | 19.0 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.6 | 7.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.6 | 11.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.5 | 2.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.5 | 9.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.5 | 64.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.5 | 6.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.5 | 2.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.5 | 4.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.5 | 11.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.5 | 1.9 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
| 0.5 | 7.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.5 | 10.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 20.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 3.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.4 | 4.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.4 | 16.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.4 | 8.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.4 | 12.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.4 | 34.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.4 | 9.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 6.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.4 | 9.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.4 | 12.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.4 | 7.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.4 | 8.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.4 | 27.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.4 | 6.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.4 | 15.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.4 | 4.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.3 | 6.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.3 | 1.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 4.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.3 | 5.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 38.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.3 | 8.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 3.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 6.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 8.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.3 | 6.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.3 | 5.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 4.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.3 | 20.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.3 | 5.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 4.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 5.5 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.3 | 3.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.3 | 3.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.3 | 8.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.3 | 3.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 9.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.3 | 7.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.3 | 1.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.3 | 5.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.3 | 4.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 5.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.3 | 12.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 6.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 3.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 2.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 2.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 6.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 8.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 15.9 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.2 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 2.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.2 | 4.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.2 | 1.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.2 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
| 0.2 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 4.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 2.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 3.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 7.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.2 | 4.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 5.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.2 | 2.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 2.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.2 | 9.4 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.2 | 11.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 1.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.2 | 0.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.2 | 3.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.2 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.2 | 6.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.2 | 1.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.2 | 6.5 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
| 0.1 | 1.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.1 | 1.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 9.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 3.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.1 | 3.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 0.8 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
| 0.1 | 1.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 7.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 3.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 0.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 0.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.1 | 23.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 3.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 21.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 1.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 7.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
| 0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.1 | 3.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 2.2 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
| 0.1 | 0.2 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
| 0.1 | 2.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 1.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.1 | 2.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 2.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 2.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.7 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 2.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.0 | 2.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |